Metabolix (YTEN)
(Delayed Data from OTC)
$0.99 USD
-0.16 (-13.91%)
Updated Sep 20, 2024 03:53 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Metabolix, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 1 | 1 | 1 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 1 | 1 | 1 |
Selling & Adminstrative & Depr. & Amort Expenses | 14 | 14 | 12 | 10 | 9 |
Income After Depreciation & Amortization | -14 | -13 | -12 | -10 | -9 |
Non-Operating Income | 0 | 0 | 1 | -1 | -5 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -14 | -13 | -11 | -10 | -13 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -14 | -14 | -11 | -10 | -13 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -14 | -14 | -11 | -10 | -13 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -14 | -13 | -11 | -9 | -8 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -14 | -13 | -12 | -10 | -9 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 0.33 | 0.21 | 0.20 | 0.10 | 0.02 |
Diluted EPS Before Non-Recurring Items | -43.65 | -66.19 | -55.88 | -103.12 | -851.32 |
Diluted Net EPS (GAAP) | -43.65 | -66.19 | -55.88 | -103.12 | -851.32 |
Fiscal Year end for Metabolix, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.45 | 0.30 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.45 | 0.30 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 3.65 | 2.74 | 3.25 | 3.70 | 3.67 |
Income After SG&A, R&D, and Dept/Amort Expenses | -3.20 | -2.44 | -3.25 | -3.70 | -3.67 |
Non-Operating Income | -0.04 | -0.03 | -0.02 | -0.02 | -0.01 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -3.24 | -2.47 | -3.27 | -3.73 | -3.68 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -3.24 | -2.47 | -3.27 | -3.73 | -3.68 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -3.24 | -2.47 | -3.27 | -3.73 | -3.68 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 0.64 | 0.52 | 0.50 | 0.38 | 0.24 |
Diluted EPS Before Non-Recurring Items | -5.04 | -4.77 | -6.47 | -9.83 | -15.35 |
Diluted Net EPS (GAAP) | -5.04 | -4.77 | -0.24 | -9.83 | -15.35 |